BSEResult18h ago · 23 Jul 2026, 01:04 pm
Financial Results along with the Limited Review Report of Novartis India Limited for the quarter ended June 30, 2026.
Novartis India Ltd · 500672
✦ AI SummaryResults
Novartis India Ltd has submitted its unaudited financial results for the quarter ended June 30, 2026, along with a limited review report from its statutory auditors.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Novartis India Ltd - 500672 - Financial Results Of Novartis India Limited For The Quarter Ended June 30, 2026.
Attachments (1)
📄pdf
Download →
155fb5bd-acc7-4f62-b613-9ab3e5ae241e.pdf
View document text
Novartis India Limited
Inspire BKC
7th Floor, Bandra Kurla Complex
Bandra East, Mumbai 400051
Maharashtra, India
Tel +91 22 50243000
Website: www.novartis.in
CIN- L24200MH1947PLC006104
Email: india.investors@novartis.com
July 23, 2026
The Secretary
BSE Limited
Phiroze Jeejeebhoy Towers,
Dalal Street,
Mumbai - 400 001
Scrip Code: 500 672
Sub.: Integrated Filing (Financial) for the quarter ended June 30, 2026.
Dear Sir/ Madam,
Pursuant to Regulation 10(1A) and other applicable provisions of SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015, SEBI Circular No. SEBI/HO/CFD/CFD-PoD2/CIR/P/2024/185 dated
December 31, 2024, read with BSE Circular No. 20250102-4 and NSE Circular No. NSE/CML/2025/02
dated January 02, 2025, we are submitting herewith the Unaudited Financial Results for the quarter ended
June 30, 2026 along with the Limited Review Report issued by the Statutory Auditors of the Company
(Annexure I & II) and other disclosures as required under the Integrated Filing (Financial) for the quarter
ended June 30, 2026.
This is for your information and records.
Thanking you,
Yours faithfully,
For Novartis India Limited
Chandni Maru
Company Secretary and Compliance Officer
A60291
Encl.: as above
Integrated Filing (Financial) for the quarter ended June 30, 2026.
A. Statement on Deviation or Variation for Proceeds of Public Issue, Rights Issue, Preferential Issue,
Qualified Institutions Placement etc.: Not Applicable.
C. Disclosure of Outstanding Default on Loans and Debt Securities: - Not Applicable.
Sr Particulars Amount
No. (INR)
1. Loans / revolving facilities like cash credit from
banks / financial institutions
A. Total amount outstanding as on date NIL
B. Of the total amount outstanding, amount of default as NIL
on date
2. Unlisted debt securities i.e. NCDs and NCRPS
A. Total amount outstanding as on date NIL
B. Of the total amount outstanding, amount of default as NIL
on date
3. Total financial indebtedness of the listed entity NIL
including short-term and long-term debt
D. Disclosure of Related Party Transactions (Applicable only for Half Yearly Filings (i.e. 02nd and 04th
Quarter): Not Applicable.
E. Statement on Impact of Audit Qualifications (For Audit Report with Modified Opinion) Submitted Along
with Annual Audited Financial Results (Standalone and Consolidated Separately) (Applicable Only for
Annual Filing i.e. 4th Quarter): Not Applicable.